Full Press Release Details
MARLBOROUGH, Mass. , Nov. 5, 2015 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) is scheduled to participate in the Canaccord Genuity 9 th Annual Medical Technology and Diagnostics Forum on November 19 , in New York City .
David Pierce , executive vice president & president, Endoscopy and Susie Lisa , vice president, Investor Relations, will participate in a 30-minute question-and-answer session regarding the company with the host analyst beginning at approximately 9:30 a.m. ET .
A live webcast of the question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com . Registration at least 15 minutes prior to the scheduled start time is encouraged to ensure a timely connection.
A replay of the webcast will be accessible at investors.bostonscientific.com beginning approximately one hour following the completion of the question-and-answer session.
About Boston Scientific Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook .
| CONTACTS | |
| Media: | Investors: |
| Kelly Leadem | Susie Lisa, CFA |
| 508-683-5543 (office) | 508-683-5565 (office) |
| Media Relations | Investor Relations |
| Boston Scientific Corporation | Boston Scientific Corporation |
| [email protected] | [email protected] |
SOURCE Boston Scientific Corporation